NEW YORK (GenomeWeb News) – BioSearch Technologies today said that it has licensed patents covering oligonucleotide components to Intelligent Medical Devices (IMDx).
According to the Novato, Calif.-based firm, it has licensed to IMDx access to patents covering its BHQ, CAL Fluor, and Quasar technologies. It also will manufacture cGMP oligonucleotides for Cambridge, Mass.-based IMDx for human in vitro diagnostic use.
Financial and other terms of the alliance were not disclosed.
IMDx is developing molecular diagnostics for the infectious diseases, oncology, and genetic testing markets.